Shoshana Shendelman - Dec 21, 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Stock symbol
APLT
Transactions as of
Dec 21, 2023
Transactions value $
$0
Form type
4
Date filed
12/22/2023, 08:01 PM
Previous filing
Dec 1, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +1.1M +42.37% $0.00 3.7M Dec 21, 2023 Direct F1
transaction APLT Common Stock Award $0 +440K +11.9% $0.00 4.14M Dec 21, 2023 Direct F2
holding APLT Common Stock 1.75M Dec 21, 2023 See footnote F3
holding APLT Common Stock 1.49M Dec 21, 2023 See footnote F4
holding APLT Common Stock 710K Dec 21, 2023 See footnote F5
holding APLT Common Stock 290K Dec 21, 2023 See footnote F6
holding APLT Common Stock 88.4K Dec 21, 2023 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 21, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
F2 Consists of compensatory Restricted Stock Units granted under the Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. These compensatory Restricted Stock Units are subject to both performance and time-based vesting requirements, subject to the reporting person continuing to provide services through each such date. The performance-based vesting requirements shall be satisfied upon the issuer's stock price trading at or above $6.00 per share for twenty consecutive trading days during a four-year performance period. The time-based vesting requirements shall be satisfied on the same schedule as applies to the time-based awards referenced in footnote (1) above.
F3 Through a grantor retained annuity trust.
F4 Through a family trust controlled by the reporting person's spouse.
F5 Through the reporting person's spouse.
F6 Through a family trust controlled by the reporting person.
F7 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.